BSD Medical Corp

Type: Company
Name: BSD Medical Corp
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

by Charles Dockendorff, the outgoing CFO at Covidien, is named to the board of directors at Haemonetics.Haemonetics  (NYSE: HAE ) added the outgoing CFO of Covidien  (NYSE: COV ), Charles Dockendorff, to its board of directors and said another director ... [Published MassDevice - Jul 28 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

BSD MEDICAL : Begins Hyperthermia Clinical Study

BSD Medical Corp. has reported initiation of a Phase I/II study (Hyprosar) using hyperthermia, delivered using either the BSD-2000 Hyperthermia System (BSD-2000) or the BSD-500 Hyperthermia System ( BSD-500 ), combined with proton radiotherapy to treat ... [Published 4 Traders - Jul 27 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 3 reports

BSD Medical Bolsters U.S. MicroThermX® Support Team with Hiring of Shella Leahy

SALT LAKE CITY--(BUSINESS WIRE)-- BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) ( www.BSDMedical.com ) today announced that it has hired Shella Leahy to provide technical, clinical, educational and field support for its MicroThermX microwave ... [Published CNBC - Jul 23 2014]
First reported Jul 21 2014 - Updated Jul 22 2014 - 2 reports

Insider Buying: BSD Medical Director Purchases 17,510 Shares of Stock (BSDM)

BSD Medical (NASDAQ:BSDM) Director Steven G. Stewart bought 17,510 shares of the company’s stock in a transaction dated Thursday, July 17th. The stock was purchased at an average price of $0.83 per share, for a total transaction of $14,533.30. Following ... [Published American Banking News - Jul 22 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 2 reports

BSD MEDICAL : Initiates Hyperthermia Clinical Study

BSD Medical Corp. has reported initiation of a Phase I/II study (Hyprosar) using hyperthermia, delivered using either the BSD-2000 Hyperthermia System (BSD-2000) or the BSD-500 Hyperthermia System ( BSD-500 ), combined with proton radiotherapy to treat ... [Published 4 Traders - Jul 18 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 4 reports

BSD Medical Hyperthermia starts Hyprosar study to treat Soft Tissue Sarcoma

BSD Medical has started a Phase I/II study (Hyprosar) using hyperthermia, delivered using either the BSD-2000 Hyperthermia System or the BSD-500 Hyperthermia System, combined with proton radiotherapy to treat patients with unresectable soft tissue sa ... [Published Medical Devices Business Review - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

BSD Medical Q3 net loss up

BSD Medical Corporation, a provider of medical systems to treat cancer and benign diseases, has reported that net loss and comprehensive loss for the third quarter ended May 31, 2014 was $1.99 million, or $0.06 loss per share, compared to a net loss and ... [Published Individual.com - Jul 16 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 2 reports

BSD Medical signs sales and distribution agreement with Comed Medical

BSD Medical Corporation, a provider of medical systems for treatment of cancer, has signed an agreement with Comed Medical Specialties for the sales and distribution of the MicroThermX Microwave Ablation line of products. Based in Salt Lake City, Utah, ... [Published Individual.com - Jul 15 2014]
First reported Jul 10 2014 - Updated Jul 11 2014 - 6 reports

BSD Medical Enters into Distribution Agreement with Comed Medical Specialties for MicroThermX Microwave Ablation Products

BSD Medical Corporation announced that the Company has signed an agreement with Comed Medical Specialties (Comed) for the sales and distribution of the MicroThermX Microwave Ablation (MicroThermX) line of products.This agreement allows Comed to market ... [Published Asian Hospital & Healthcare Management - Jul 11 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

BSD Medical Announces Third Quarter Fiscal 2014 Financial Results

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for the three ... [Published Business Wire Health News - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 3 reports

BSD Medical Hyperthermia Systems Featured at European Society for Hyperthermic Oncology Annual Conference

SALT LAKE CITY--(BUSINESS WIRE)-- BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced BSD hyperthermia systems were featured in multiple ... [Published Investor's Business Daily - Jul 09 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 9 reports

Huntsman Cancer Institute Becomes Teaching Center for Microwave Treatment System

ArticlePress Release July 8, 2014Salt Lake City – BSD Medical Corporation, a provider of medical systems that treat cancer and benign diseases using heat therapy, has reported that University of Utah’s Huntsman Cancer Institute (HCI) has been established ... [Published Utah Business Magazine - Jul 08 2014]

Quotes

"Chuck is a highly-respected healthcare industry leader.  He brings an extensive financial management and planning background to our board, along with considerable experience with one of the world's premier healthcare products companies. His contributions will help to guide the company as it seeks to grow market share and provide industry leading returns to shareholders" Haemonetics chairman Richard Meelia – himself a Covidien veteran who retired as CEO in 2011 – said in prepared remarks
Datta concluded, "Consequently, for unresectable primary and recurrent soft tissue sarcomas, the thermoradiobiological and physical advantages of hyperthermia and proton beam radiotherapy could be expected to produce a greater tumour regression, higher tumour downstaging, superior resectability with organ and limb preservation and improved survival outcome without significant treatment related morbidity."
"While growing revenues we have kept tight control over operating expenses and reduced our year-to-date net loss by more than $1 million. With our costs in check and recently strengthened cash position, we are well positioned for continued growth" added Mr Wolcott
...With our costs in check and recently strengthened cash position, we are well positioned for continued growth," added Wolcott. " Terumo is an excellent distribution partner for the MTX product line, with exclusive license to sell in more than 100 countries in the greater Europe area, and we are seeing growing interest in that part of the world. There is an emerging body of evidence and acceptance of the use of microwave ablation technology in the treatment of cancer, both domestically and abroad, which bodes well for BSD's future."

More Content

All (119) | News (54) | Reports (0) | Blogs (65) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Haemonetics taps outgoing Covidien CFO Dockendo... [Published MassDevice - Jul 28 2014]
BSD MEDICAL : Begins Hyperthermia Clinical Study [Published 4 Traders - Jul 27 2014]
United States Gynecological Devices Market Outl... [Published SBWire - Jul 24 2014]
BSD Medical Bolsters U.S. MicroThermX® Support ... [Published CNBC - Jul 23 2014]
BSD Medical Bolsters U.S. MicroThermX® Support ... [Published Business Wire Education News - Jul 23 2014]
BSD Medical Bolsters U.S. MicroThermX® Support ... [Published Business Wire Health News - Jul 23 2014]
Insider Buying: BSD Medical Director Purchases ... [Published American Banking News - Jul 22 2014]
Insider Buying: Steven G. Stewart Purchases 17,... [Published American Banking News - Jul 21 2014]
BSD MEDICAL : Initiates Hyperthermia Clinical S... [Published 4 Traders - Jul 18 2014]
BSD Medical initiates Phase I/II soft tissue sa... [Published Individual.com - Jul 17 2014]
BSD Medical Hyperthermia starts Hyprosar study ... [Published Medical Devices Business Review - Jul 16 2014]
BSD Medical Q3 net loss up [Published Individual.com - Jul 16 2014]
Clinical study will combine hyperthermia with p... [Published MedicalPhysicsWeb - Jul 16 2014]
BSD MEDICAL : Releases Third Quarter Financial ... [Published 4 Traders - Jul 16 2014]
Healthcare Review: Aratana Therapeutics, BSD Me... [Published BioMedReports - Jul 15 2014]
BSD initiates hyperthermia clinical trial [Published Seeking Alpha - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published BioPortfolio - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
2020 United States Gynecological Devices Indust... [Published MyNewsDesk - Jul 15 2014]
BSD Medical signs sales and distribution agreem... [Published Individual.com - Jul 15 2014]
BSD Medical, Comed Medical Specialties sign dis... [Published Medical Devices Business Review - Jul 14 2014]
TERUMO : BSD Medical Announces Third Quarter Fi... [Published 4 Traders - Jul 11 2014]
BSD Medical Enters into Distribution Agreement ... [Published Asian Hospital & Healthcare Management - Jul 11 2014]
Healthcare Review: Ocera Therapeutics, BSD Medi... [Published BioMedReports - Jul 10 2014]
BSD Medical reports Q3 results, inks Comed deal [Published Aunt Minnie - Jul 10 2014]
BSD Medical fiscal Q3 results [Published Seeking Alpha - Jul 10 2014]
BSD Medical Signs Distribution Agreement with C... [Published BusinessWeek - Jul 10 2014]
BSD Medical Signs Distribution Agreement with C... [Published Business Wire Health News - Jul 10 2014]
BSD Medical Announces Third Quarter Fiscal 2014... [Published BusinessWeek - Jul 10 2014]
BSD Medical Announces Third Quarter Fiscal 2014... [Published Business Wire Health News - Jul 10 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BSD Medical Bolsters U.S. MicroThermX® Support ... [Published Business Wire Education News - Jul 23 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that it has hired Shella Leahy to provide technical, clinical, educational and field support for its MicroThermX microwave ablation ...
BSD Medical Bolsters U.S. MicroThermX® Support ... [Published Business Wire Health News - Jul 23 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that it has hired Shella Leahy to provide technical, clinical, educational and field support for its MicroThermX microwave ablation ...
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported initiation of a Phase I/II study (HYPROSAR) using ...
BSD Medical Signs Distribution Agreement with C... [Published Business Wire Health News - Jul 10 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has signed an agreement with ...
BSD Medical Announces Third Quarter Fiscal 2014... [Published Business Wire Health News - Jul 10 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for the three ...
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.